Embody, Inc., a Norfolk, Virginia-based soft tissue healing company, has appointed a new board member and expanded its leadership team.
Founded in 2014, Embody focuses on developing biomaterials for use in orthopedic sports medicine. The company recently completed an oversubscribed $20.5 million funding round. For OTW’s coverage of Embody’s recent funding round, see “Embody Raises $20.5 Million in New Funding.”
Embody has appointed Rene Salas to its board of directors. Salas has over 30 years of experience working with health and technology companies. He is a retired partner from Ernst & Young where he led the Mid-Atlantic life science practice.
Embody Chief Executive Officer Jeff Conroy commented, “We are honored to have Rene’s [Salas] experience of working closely with high growth life science companies that have gone public, generating more than $5B [billion] in transactions to our board.”
Embody has also expanded its leadership team. The recent hires and appointments will help drive the company’s expansion.
Tim Meyers has been named chief financial officer. Meyers is a familiar face at Embody, most recently serving on its board of directors. In his new role, Meyers will bring his experience of “assisting more than 150 companies through capital raises, mergers, and acquisitions.”
The other additions to the Embody executive team bring significant orthobiologics, product development, commercial operations, and regulatory experience. Embody’s new executives include the following individuals: Matt Havener, director of product development; Vicki Phillos, director of commercial operations; Brianna Schehr, director of regulatory and clinical; Jack Gardella, director of national accounts; and Christine Nelson, vice president of manufacturing and quality (Nelson has been with Embody for over four years).
Conroy also commented on the new additions in the press release, stating, “We see tremendous growth potential based on our recent success, requiring the need to build a team that is equipped to scale.”
Conroy continued, “With these new additions, we are in a position to further expand our capabilities and help our customers benefit from our technologies.”
